Actualités DMK Pharmaceuticals Corporation - DMK | Actions NASDAQ | ADVFN

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
DMK Pharmaceuticals Corporation (DMK)
DMK Pharmaceuticals Corporation (DMK) Actualités

DMK Pharmaceuticals Corporation (DMK)

0,232

0,00

( 0,00% )

Mis à jour : 01:00:00

Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 8-K - Current report

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (Nasdaq: DMK) (“DMK”), a...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form 8-K - Current report

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

DMK Pharmaceuticals

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales